Enterome
Clinical trials sponsored by Enterome, explained in plain language.
-
Experimental vaccine combo for rare adrenal cancers shows early promise but trial halted
Disease control TerminatedThis early-phase trial tested a new therapeutic vaccine (EO2401) combined with the immunotherapy drug nivolumab in 70 people with advanced adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma. The goal was to see if the combination is safe and can shrink tumors or…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cancer vaccine trial for colorectal cancer halted after just one patient
Disease control TerminatedThis phase 2 trial tested a combination of a therapeutic vaccine (EO2040) and an immunotherapy drug (nivolumab) in colorectal cancer patients who had minimal residual disease detected by a blood test after completing standard treatment. The goal was to clear remaining cancer cell…
Phase: PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC